Brind.

AbbVie, Alcon, and Johnson & Johnson are key players in the Saudi Arabian over-the-counter artificial tears market.

1 report, 1 independent Updated Aug 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

AbbVie Saudi Arabia Alcon

Keep exploring

The entities involved

AbbVie
pharmaceutical company
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
- AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
Saudi Arabia
country in West Asia
- Escalating conflict involves Iran and Saudi Arabia, with fighting intensifying between Saudi-backed forces and Houthis. Karami warns of a firm response to miscalculation.Mon 17:52
- Ishaq Dar attended an R-4 meeting in Cairo today, contributing to ongoing diplomatic efforts.Mon 17:12
Alcon
medical company
- Land Rover is utilizing Alcon brake setups and Eibach coil springs in an upgrade package.Fri 12:00

Coverage

Newest first; wire copies grouped

Aug 7GlobeNewswireSaudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical